741 related articles for article (PubMed ID: 17925066)
21. Drugs for asthma.
Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of beta agonists.
Donohue JF
Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
24. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
25. Bronchodilators: new drugs and controversies.
Kleerup EC
Curr Opin Pulm Med; 1997 Jan; 3(1):17-22. PubMed ID: 9139768
[TBL] [Abstract][Full Text] [Related]
26. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
Nelson HS; Carr W; Nathan R; Portnoy JM
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):11-5. PubMed ID: 19205279
[TBL] [Abstract][Full Text] [Related]
27. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
28. [Role of long-acting beta-agonists in the treatment of asthma].
Marti C; Janssens JP; Rutschmann O
Rev Med Suisse; 2008 Oct; 4(175):2203-4, 2206-7. PubMed ID: 19024574
[TBL] [Abstract][Full Text] [Related]
29. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
30. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
Hui KP
Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
[TBL] [Abstract][Full Text] [Related]
31. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
[TBL] [Abstract][Full Text] [Related]
32. Medications for COPD: a review of effectiveness.
Grimes GC; Manning JL; Patel P; Via RM
Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity in response to asthma medications.
Tamesis GP; Krawiec ME
Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):185-9. PubMed ID: 17351474
[TBL] [Abstract][Full Text] [Related]
34. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients.
Syamsu ; Yusuf I; Budu ; Patellongi I
Acta Med Indones; 2007; 39(1):8-12. PubMed ID: 17297203
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
ten Hacken NH; Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetic tests in asthma therapy.
Yu IW; Bukaveckas BL
Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
[TBL] [Abstract][Full Text] [Related]
37. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
38. Increased perception of dyspnea by inhalation of short acting beta2 agonist in patients with asthma of varying severity.
Jang AS; Choi IS
Ann Allergy Asthma Immunol; 2000 Jan; 84(1):79-83. PubMed ID: 10674569
[TBL] [Abstract][Full Text] [Related]
39. Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1992-2002.
Molfino NA
Medicina (B Aires); 2004; 64(5):407-12. PubMed ID: 15560541
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics of β2-agonists.
Hizawa N
Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
